BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 17044568)

  • 21. Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas.
    Losa M; Bogazzi F; Cannavo S; Ceccato F; Curtò L; De Marinis L; Iacovazzo D; Lombardi G; Mantovani G; Mazza E; Minniti G; Nizzoli M; Reni M; Scaroni C
    J Neurooncol; 2016 Feb; 126(3):519-25. PubMed ID: 26614517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Temozolomide treatment of a pituitary carcinoma and two pituitary macroadenomas resistant to conventional therapy.
    Hagen C; Schroeder HD; Hansen S; Hagen C; Andersen M
    Eur J Endocrinol; 2009 Oct; 161(4):631-7. PubMed ID: 19654234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Management of patients with non-functioning pituitary adenomas. Summary of results of an expert conference of the Hypophysis Work Group of the German Society of Endocrinology, Friedewald, 15-17 February 2002].
    Lüdecke DK
    Med Klin (Munich); 2003 Nov; 98(11):616-27. PubMed ID: 14631537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of prolactin-secreting pituitary carcinoma and its histological findings.
    Noda M; Suzuki R; Moriya M; Itokawa H; Asai J; Nagashima G; Fujimoto T
    Brain Tumor Pathol; 2004; 21(3):149-54. PubMed ID: 15696977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Does resection of pituitary adenoma and radiotherapy cure the patient's symptoms?].
    Buchfelder M
    MMW Fortschr Med; 2001 Nov; 143(44):40-2. PubMed ID: 11732395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Giant prolactinomas: clinical management and long-term follow up.
    Shrivastava RK; Arginteanu MS; King WA; Post KD
    J Neurosurg; 2002 Aug; 97(2):299-306. PubMed ID: 12186457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant prolactinoma with multiple bone and pulmonary metastases. Case report.
    Lamas C; Núñez R; García-Uría J; Salas C; Saucedo G; Estrada J; Parajón A; Lucas T
    J Neurosurg; 2004 Aug; 101(1 Suppl):116-21. PubMed ID: 16206983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multimodality treatment of pituitary adenomas.
    Oyesiku NM
    Clin Neurosurg; 2005; 52():234-42. PubMed ID: 16626076
    [No Abstract]   [Full Text] [Related]  

  • 29. Prolactin secreting adenoma in 22 men.
    Grisoli F; Vincentelli F; Jaquet P; Guibout M; Hassoun J; Farnarier P
    Surg Neurol; 1980 Apr; 13(4):241-7. PubMed ID: 7376059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Temozolomide therapy for resistant prolactin-secreting pituitary adenomas and carcinomas: a systematic review.
    Almalki MH; Aljoaib NN; Alotaibi MJ; Aldabas BS; Wahedi TS; Ahmad MM; Alshahrani F
    Hormones (Athens); 2017 Apr; 16(2):139-149. PubMed ID: 28742502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prolactin-secreting macroadenoma in an adolescent girl: response to the medical treatment and follow-up method].
    de Kerdanet M; Lebrethon MC; Lecornu M
    Pediatrie; 1993; 48(3):233-6. PubMed ID: 8393981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of temozolomide in a patient with recurring oncocytic gonadotrophic pituitary adenoma.
    Syro LV; Scheithauer BW; Ortiz LD; Fadul CE; Horvath E; Rotondo F; Kovacs K
    Hormones (Athens); 2009; 8(4):303-6. PubMed ID: 20045804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple intracranial recurrent tumors with hyperprolactinemia combined with a parasellar malignant fibrous histiocytoma long after transfrontal surgery and irradiation to a pituitary adenoma.
    Fujikawa M; Okamura K; Sato K; Shiratsuchi M; Yao T; Mizokami T; Fujishima M
    J Endocrinol Invest; 2001 Jun; 24(6):448-53. PubMed ID: 11434670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid-stimulating hormone pituitary adenomas.
    Clarke MJ; Erickson D; Castro MR; Atkinson JL
    J Neurosurg; 2008 Jul; 109(1):17-22. PubMed ID: 18590428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of resistant prolactinomas.
    Olafsdottir A; Schlechte J
    Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):552-61. PubMed ID: 17024154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of hypophyseal prolactin-secreting macroadenomas].
    Candrina R; Tosoni M
    Recenti Prog Med; 1989 Sep; 80(9):471-3. PubMed ID: 2595078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the Leksell gamma knife in the treatment of prolactinoma patients.
    Jezková J; Hána V; Krsek M; Weiss V; Vladyka V; Liscák R; Vymazal J; Pecen L; Marek J
    Clin Endocrinol (Oxf); 2009 May; 70(5):732-41. PubMed ID: 18710463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pituitary carcinoma with a single metastasis causing cervical spinal cord compression. Case report.
    Ayuk J; Natarajan G; Geh JI; Mitchell RD; Gittoes NJ
    J Neurosurg Spine; 2005 Mar; 2(3):349-53. PubMed ID: 15796362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
    Kawabata Y; Ueno Y; Horikawa F; Miyake H; Miki N; Ono M
    Surg Neurol; 2008 Jan; 69(1):85-8; discussion 88. PubMed ID: 17967478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.